According to a new report "Global Opportunities in Obesity Management Technologies"--distributed exclusively by Life Science Intelligence and published by Health Research International--an estimated 1.3 billion people representing nearly 30% of the global adult population are overweight or obese, and the share is more than twice that in the U.S., Mexico, and selected nations of Europe and the Middle East.

Including its contribution to diabetes and cardiovascular disease, this epidemic is placing heavy demands on nations' health delivery systems and shining a bright light on the unmet need for new approaches and products that can manage and reverse this trend. Diet, exercise programs, and drugs have proven largely ineffective for most patients, and surgery remains an option only for the morbidly obese.

Clearly, two solutions are needed:

  • The first must address the significant patient population that is already morbidly or severely obese, enabling them to both lose excess weight and moderate the costly health conditions associated with their obesity.
  • The second must provide means for individuals currently overweight or mildly obese to reverse the progression of their disease, thereby slowing and even halting the epidemic.

Device-based options that provide anatomic solutions with low physiologic and safety risks represent the best opportunity to achieve these two goals at present. Their uptake will be expedited by a growing private-pay market, which will itself be driven by the growing number of bariatric clinics that offer multiple treatment choices, supported by nutritional and monitoring support. The result will be a rapidly expanding, multi-billion dollar global market for obesity management procedures and technologies that will be shaped by ease-of-use and long-term clinical outcomes.

These are among the findings in the new data-intensive report "Global Opportunities in Obesity Management Technologies", which provides "must have" econometric market models and analysis of the trends and emerging technologies impacting the market through 2018. Coverage includes:

  • 10 Procedure Categories
  • 7 Major Technology Markets
  • 5 Geographies
  • 43 Company Profiles

Because many of the technologies lack long-term outcomes, the report forecasts fairly marginal penetration of the total addressable market. Nevertheless, this translates into several billion dollars in revenues based on the magnitude of the global obesity epidemic.

Immediate access to the Table of Contents is available at: www.lifescienceintelligence.com/market-reports-page.php?id=HRI-071

About Health Research International (HRI)

Since 1978, Health Research International (www.healthri.com) has been providing the pharmaceutical and medical device industries with reliable, comprehensive, and meticulously researched custom market data and analysis. Quality, experience, and a thorough understanding of competing medical technologies have been the cornerstones of our custom consulting, on-line surveys, and market reports.

About Life Science Intelligence (LSI)®

LSI delivers global market research products to biotechnology, medical device, and pharmaceutical manufacturers, investors, and service companies. Our vast research capabilities extend from off-the-shelf reports and data, to customized intelligence for specific projects.

Life Science Intelligence
Scott Pantel, 1-714-847-3540
scott@LifeScienceIntelligence.com
www.LifeScienceIntelligence.com